Methylnaltrexone vs Naloxegol in the Treatment of Opioid-Induced Constipation
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy of subcutaneous versus oral mu-opioid
receptor antagonist therapy in opioid induced constipation that is refractory to other bowel
regimens.